Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Community-based HCV screening: knowledge and attitudes in a high risk urban population.

Norton BL, Voils CI, Timberlake SH, Hecker EJ, Goswami ND, Huffman KM, Landgraf A, Naggie S, Stout JE.

BMC Infect Dis. 2014 Feb 10;14:74. doi: 10.1186/1471-2334-14-74.

PMID:
24512462
[PubMed - in process]
Free PMC Article
2.

Antiviral treatment of hepatitis C virus infection and factors affecting efficacy.

Zhu Y, Chen S.

World J Gastroenterol. 2013 Dec 21;19(47):8963-73. doi: 10.3748/wjg.v19.i47.8963. Review.

PMID:
24379621
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Diversity of Hepatitis C virus in Southern India Based on 5'UTR Sequence.

Amjesh R, Nair AS, Sugunan VS.

Indian J Virol. 2012 Dec;23(3):349-53. doi: 10.1007/s13337-012-0103-2. Epub 2012 Sep 25.

PMID:
24293823
[PubMed]
Free PMC Article
4.

Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C.

García-Samaniego J, Romero M, Granados R, Alemán R, Jorge Juan M, Suárez D, Pérez R, Castellano G, González-Portela C.

World J Gastroenterol. 2013 Mar 28;19(12):1943-52. doi: 10.3748/wjg.v19.i12.1943.

PMID:
23569340
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Efficacy and safety of low-dose peginterferon alpha-2a plus ribavirin on chronic hepatitis C.

Yan Z, Fan K, Wang X, Mao Q, Deng G, Wang Y.

Gastroenterol Res Pract. 2012;2012:302093. doi: 10.1155/2012/302093. Epub 2012 Dec 3.

PMID:
23258976
[PubMed]
Free PMC Article
6.

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.

Pembroke T, Rees I, Gallagher K, Jones E, Mizen P, Navruzov T, Freedman A, Fielding C, Humphreys IR, Wang EC, Gallimore AM, Godkin A.

Eur J Immunol. 2012 Sep;42(9):2383-94. doi: 10.1002/eji.201142072. Epub 2012 Aug 6.

PMID:
22653709
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A pilot training program for a motivational enhancement approach to hepatitis C virus treatment among individuals in Israeli methadone treatment centers.

Morse DS, Schiff M, Levit S, Cohen-Moreno R, Williams GC, Neumark Y.

Subst Use Misuse. 2012 Jan;47(1):56-66. doi: 10.3109/10826084.2011.628735.

PMID:
22216992
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prediction of effect of pegylated interferon alpha-2b plus ribavirin combination therapy in patients with chronic hepatitis C infection.

Takayama T, Ebinuma H, Tada S, Yamagishi Y, Wakabayashi K, Ojiro K, Kanai T, Saito H, Hibi T; Keio Association for the Study of Liver Diseases.

PLoS One. 2011;6(12):e27223. doi: 10.1371/journal.pone.0027223. Epub 2011 Dec 2.

PMID:
22164207
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study.

Harris HE, Costella A, Amirthalingam G, Alexander G, Ramsay ME, Andrews N; UK HCV National Register Collaborators; UK HCV National Register Steering Group.

Epidemiol Infect. 2012 Oct;140(10):1830-7. Epub 2011 Nov 29.

PMID:
22124380
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.

Demetriou VL, Kostrikis LG.

BMC Res Notes. 2011 Oct 31;4:468. doi: 10.1186/1756-0500-4-468.

PMID:
22040780
[PubMed]
Free PMC Article
11.

Current treatment of choice for chronic hepatitis C infection.

Yasin T, Riley TR, Schreibman IR.

Infect Drug Resist. 2011;4:11-8. doi: 10.2147/IDR.S4827. Epub 2011 Jan 12.

PMID:
21694905
[PubMed]
Free PMC Article
12.

Risk factors and genotypes of hepatitis C virus infection in libyan patients.

Alashek W, Altagdi M.

Libyan J Med. 2008 Dec 1;3(4):162-5. doi: 10.4176/080425.

PMID:
21499468
[PubMed]
Free PMC Article
13.

Boceprevir for previously treated chronic HCV genotype 1 infection.

Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R; HCV RESPOND-2 Investigators.

N Engl J Med. 2011 Mar 31;364(13):1207-17. doi: 10.1056/NEJMoa1009482.

PMID:
21449784
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Predictors of virological response to a combination therapy with pegylated interferon plus ribavirin including virus and host factors.

Izumi N, Asahina Y, Kurosaki M.

Hepat Res Treat. 2010;2010:703602. doi: 10.1155/2010/703602. Epub 2010 Sep 5.

PMID:
21188200
[PubMed]
Free PMC Article
15.

Efficacy and safety of a novel pegylated interferon alpha-2a in Egyptian patients with genotype 4 chronic hepatitis C.

Taha AA, El-Ray A, El-Ghannam M, Mounir B.

Can J Gastroenterol. 2010 Oct;24(10):597-602.

PMID:
21037988
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Evidence-based clinical guidelines for immigrants and refugees.

Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M, Narasiah L, Kirmayer LJ, Ueffing E, MacDonald NE, Hassan G, McNally M, Khan K, Buhrmann R, Dunn S, Dominic A, McCarthy AE, Gagnon AJ, Rousseau C, Tugwell P; coauthors of the Canadian Collaboration for Immigrant and Refugee Health.

CMAJ. 2011 Sep 6;183(12):E824-925. doi: 10.1503/cmaj.090313. Epub 2010 Jun 7. No abstract available.

PMID:
20530168
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Sustained virological response in a predominantly hepatitis C virus genotype 4 infected population.

Dahlan Y, Ather HM, Al-ahmadi M, Batwa F, Al-hamoudi W.

World J Gastroenterol. 2009 Sep 21;15(35):4429-33.

PMID:
19764095
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Pang PS, Planet PJ, Glenn JS.

PLoS One. 2009 Aug 11;4(8):e6579. doi: 10.1371/journal.pone.0006579.

PMID:
19668364
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Influence of quasispecies on virological responses and disease severity in patients with chronic hepatitis C.

Kumar D, Malik A, Asim M, Chakravarti A, Das RH, Kar P.

World J Gastroenterol. 2008 Feb 7;14(5):701-8.

PMID:
18205258
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection.

Howard AA, Lo Y, Floris-Moore M, Klein RS, Fleischer N, Schoenbaum EE.

AIDS. 2007 Mar 12;21(5):633-41.

PMID:
17314526
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk